Health News Releases

  • Today October 6
“The incidence of breast cancer in women is seeing an upward trend in the world, and today we can sa
December 08, 2023 16:10
World Renowned Cancer Researchers From Spain and U.S. Join Forces to Address Critical Needs and Challenges in Women’s Cancer Research
Mary Kay Inc. (https://marykayglobal.com/), the world's No. 1 direct selling skin care and color cosmetics brand[1] and its company-sponsored foundations, including the Mary Kay Ash Foundation (https:
Professor Heinz Gisslinger, MedUni Vienna/Austria (Fotocredit: IntMedCom)
December 08, 2023 14:15
Blood Cancer: AOP Health Announces New Findings in Patients With Polycythemia Vera to Be Presented at the American Society of Hematology (ASH) 65th Annual Meeting
AOP Orphan Pharmaceuticals GmbH (AOP Health), Vienna, Austria, announced the results of an analysis assessing the impact of an individually optimized dosing regimen of ropeginterferon alfa-2b on treat
December 07, 2023 14:30
ReNAgade Therapeutics Appoints Paul Perreault to Board of Directors
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced the appointment of Paul Perreault to its Board of Directors, effective December 5, 2023. Mr. Perre
December 07, 2023 11:20
PDC*line Pharma Completes Enrolment of Four Cohorts of Patients in PDC-LUNG-101 Phase I/II Clinical Trial
PDC*line Pharma, a clinical stage biotech company developing a new class of potent and scalable active immunotherapies for cancers, today announces completion of enrolment of the fourth cohort of pati
December 06, 2023 13:45
Merck Provides Update on Phase III Results for Evobrutinib in Relapsing Multiple Sclerosis
Merck, a leading science and technology company, today announced that its two Phase III EVOLUTION clinical trials (evolutionRMS 1 and evolutionRMS 2) investigating the efficacy and safety of evobrutin
December 06, 2023 10:45
Takeda and The New York Academy of Sciences Announce 2024 Innovators in Science Award Winners
Takeda (TSE:4502/NYSE:TAK (https://www.takeda.com/investors/overview/)) and The New York Academy of Sciences today announced the winners of the 2024 Innovators in Science Award for their excellence in
QPS Missouri is a division of QPS Holdings, LLC, a global Contract Research Organization. QPS Missou
December 05, 2023 10:35
QPS Holdings, LLC Expands Operations in Springfield, Missouri
QPS Holdings, LLC, a global contract research organization has expanded operations in Springfield, Missouri. The new facilities include a clinical (safety) laboratory, an updated self-contained pharma
Stand Tall in the face of disaster with IFRC-DREF Insurance. (Photo: Business Wire)
December 05, 2023 10:25
IFRC-DREF calls on global donors to help the world ‘Stand Tall’ in the face of accelerating humanitarian need - supporting smarter and faster disaster relief
The International Federation of Red Cross and Red Crescent Societies (IFRC (https://www.ifrc.org/)) has launched a new campaign to address rapidly escalating climate driven humanitarian crises. It cal
December 05, 2023 10:10
Merck Strengthens Oncology Portfolio Through Commercialization Agreement With Abbisko for Phase III Asset, Pimicotinib
Merck, a leading science and technology company, today announced a license agreement with Abbisko Therapeutics Co. Ltd., Shanghai, China, for pimicotinib (ABSK021), which is currently being evaluated
Ultra-low temperature freezer farm units at Mach 2 Pharmafreight’s Netherlands facility. (Photo: Bus
December 05, 2023 09:50
AIT Worldwide Logistics acquires European life sciences specialist Mach II Shipping Ltd
AIT Worldwide Logistics, a global supply chain solutions leader, has acquired Mach II Shipping Ltd, a U.K.-based freight forwarder specializing in worldwide distribution of pharmaceuticals and related
December 04, 2023 15:30
Global donors pledge over US$777 million to defeat neglected tropical diseases and improve the lives of 1.6 billion people at the Reaching the Last Mile Forum at COP28
Global donors at the 2023 Reaching the Last Mile Forum today pledged a collective US$777.2 million to help control, eliminate, and eradicate neglected tropical diseases (NTDs), in a landmark push to a
Expand businesses into growing markets in the APAC region with Healthcare+ Expo Taiwan. Join medical
December 04, 2023 14:15
Beyond Medtech: Healthcare+ Expo Taiwan Sets New Stage for Global Innovation in Future AI Healthcare
The Healthcare+ Expo Taiwan, currently taking place at Nangang Exhibition Hall 1 from November 30 to December 3, 2023, is poised to redefine the landscape of AI healthcare on a global scale. This year
QPS Neuropharmacology facility in Grambach, Austria. (Graphic: Business Wire)
December 01, 2023 13:10
QPS Holdings, LLC divests its Neuropharmacology Business Unit
Today QPS Holdings, LLC (QPS) a leading drug development Contract Research Organization (CRO), announces an agreement to sell its Neuropharmacology business unit (QPS Neuropharmacology) to Scantox, a
December 01, 2023 11:50
Fujirebio and Sysmex Expand CDMO Partnership into the Field of Neurodegenerative Diseases under Their Immunoassay Collaboration
Fujirebio Holdings, Inc. (President & CEO: Goki Ishikawa) and Sysmex Corporation (President: Kaoru Asano) today announced that they have entered into an agreement to expand their Contract Development
November 30, 2023 15:36
Results From Galderma’s Phase IIIb Trials Demonstrate Rapid and Long-Lasting Effect of RelabotulinumtoxinA on Crow’s Feet and Frown Lines
Galderma announced today topline results from two phase IIIb trials investigating RelabotulinumtoxinA for the treatment of glabellar lines (GL - frown lines) and lateral canthal lines (LCL - crow’s fe
November 30, 2023 15:15
ReValve Solutions Announces Successful First-in-Human with Next Generation TMVR Technology
ReValve Solutions Inc. (ReValve), which has developed a next generation technology for Transcatheter Mitral Valve Replacement (TMVR), announced that an 81-year-old male, with a history of heart failur
Discover the opportunities and challenges for medical practice leaders in evaluating their platforms
November 29, 2023 13:50
Healthcare Leaders Cite Automation, Worker Burnout as Top Drivers of Technology Integrations, MGMA and Laserfiche Study Finds
New research by Medical Group Management Association (MGMA) and Laserfiche (https://www.laserfiche.com/?utm_content=mgma2023&utm_campaign=healthcare) — the leading SaaS provider of intelligent content
November 29, 2023 11:50
Kenvue to Participate in the Morgan Stanley Global Consumer & Retail Conference on December 6, 2023
Kenvue Inc. (NYSE: KVUE) (“Kenvue”), the world’s largest pure-play consumer health company by revenue, today announced the company’s participation in Morgan Stanley’s Global Consumer & Retail Conferen
Figure 1: Area of health concern (Graphic: Business Wire)
November 28, 2023 13:20
Kirin iMUSE Immune Care and Healthya Visceral Fat Down will go on sale on Tuesday, November 28!
Kirin Holdings Company, Limited (TOKYO:2503) will launch a dual-care functional food supplement Kirin iMUSE Immuno-Care and Healthya Visceral Fat Down on November 28 (Tuesday). This product is a colla
APR Corp.
November 27, 2023 09:00
APR Achieves Consolidated Sales of KRW 122 Billion and Consolidated Operating Profit of KRW 21.7 Billion in Q3 2023
APR Corp. (https://www.apr-in.com/) (APR, CEO: Byunghoon Kim), a global beauty tech company, broke its record-high performance in Q3 2023. APR disclosed on November 14 that it had consolidated sal
November 26, 2023 13:59
Boehringer Ingelheim receives approval for SENVELGO® in Europe: the first oral liquid medication for diabetic cats
Boehringer Ingelheim, a global leader in animal health, has received marketing authorization from the European Commission for SENVELGO® (active ingredient: velagliflozin), marking a significant step f
Joint Research Results (Summary) (Graphic: Business Wire)
November 26, 2023 13:36
Japan’s First Discovery*1 on Visceral Fat and Immune Activity in Joint Research by Kirin Holdings and Kao
Kirin Holdings Company, Limited (TOKYO:2503) and Kao Corporation (TOKYO:4452) will participate in the Wakayama Health Promotion Study, a cohort study*2 led by Wakayama Medical University and organized
November 23, 2023 09:50
Boehringer Ingelheim expands immuno-oncology portfolio with the acquisition of bacterial cancer therapy specialist T3 Pharma
Boehringer Ingelheim today announced the acquisition of privately-held T3 Pharmaceuticals AG (“T3 Pharma”), a clinical stage Swiss biotech company, for an amount of up to 450 million CHF. T3 Pharma ha
November 22, 2023 10:40
AstraZeneca launches Evinova, a health-tech business to accelerate innovation across the life sciences sector, the delivery of clinical trials and better health outcomes
AstraZeneca today launches Evinova, set to be a leading provider of digital health solutions to better meet the needs of healthcare professionals, regulators and patients. With long-term backing from
November 21, 2023 16:35
Galderma Reports Record Net Sales of Over 3 B USD for the First Nine Months of 2023 With Strong Growth Momentum Across All Product Categories
Galderma: ·Galderma achieved net sales of 3,009 M USD over the first nine months of 2023, up 8.9% year-on-year on a constant currency basis ·Continued pipeline progress with new milestones reached
MicroVention Celebrates 10-Year Anniversary and Legacy of SOFIA™ Aspiration Catheters; More than 500
November 19, 2023 12:41
MicroVention Celebrates 10-Year Anniversary and Legacy of SOFIA™ Aspiration Catheters; More than 500,000 Procedures Performed Worldwide Across 170 Countries
MicroVention, Inc., a global neurovascular company and wholly owned subsidiary of Terumo Corporation, is celebrating a decade of legacy innovation commemorating the anniversary of SOFIA™ and SOFIA™ Fl
Backed by clinical evidence, B. breve B-3 shows great promise in aiding body fat reduction. (Graphic
November 19, 2023 11:19
Morinaga Milk’s Probiotic Bifidobacterium breve B-3 Receives Approval of Individual Recognized Registration in South Korea
Morinaga Milk Industry Co., Ltd. (https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.morinagamilk.co.jp%2Fenglish%2F&esheet=53837044&newsitemid=20231116301397&lan=en-US&anchor=Morina
November 17, 2023 17:15
Evidation Selected by Our Future Health as Participant Platform for UK’s Largest Health Research Program
Evidation (https://evidation.com/) — the company creating new ways to measure and improve health in everyday life — today announced a landmark partnership with Our Future Health (https://ourfutureheal
November 17, 2023 11:30
SMK Entered into Capital and Business Alliance Agreement with Canary Speech (US)
SMK Corporation (TOKYO: 6798) (https://www.smk.co.jp/) (President, CEO and COO: Yasumitsu Ikeda, hereinafter referred to as SMK) announced that it has entered into a capital and business alliance agre
November 15, 2023 11:30
Ketamine Clinic in Japan for Inbound Medical Treatment: Nagoya Anesthesia Clinic
Nagoya Anesthesia Clinic (https://nagoyamasui.com/2-2), located in Nagoya City, Aichi Prefecture, Japan, has initiated inbound medical treatment for treatment-resistant depression, other mental disord
November 12, 2023 11:00
GenScript ProBio Signs Viral Vector Manufacturing MOU With Curocell for Next-Generation CAR-T Therapy
On November 10, a global multimodality CDMO, GenScript ProBio and specialized CAR-T therapy firm Curocell signed a strategic partnership MOU for the production of viral vectors necessary for the devel
November 10, 2023 17:40
Takeda Receives U.S. FDA Approval of FRUZAQLA™ for Previously Treated Metastatic Colorectal Cancer
Takeda (TSE:4502/NYSE:TAK (https://www.takeda.com/investors/overview/)) today announced that the U.S. Food and Drug Administration (FDA) has approved FRUZAQLA™ (fruquintinib), an oral targeted therapy
November 10, 2023 12:00
GenScript ProBio Partners With NuclixBio to Pave the Way for South Korea’s First Large-scale Production Process for ‘Circular RNA Therapeutics’
GenScript ProBio, a global multimodality CDMO and NuclixBio, a company developing treatments based on circular RNA, announced on 9th Nov that they have entered into a strategic business agreement to d
November 10, 2023 11:15
Takeda’s ADZYNMA Approved by U.S. FDA as the First and Only Recombinant ADAMTS13 Enzyme Replacement Therapy for the Treatment of Congenital Thrombotic Thrombocytopenic Purpura
Takeda (https://www.takeda.com/) (TSE:4502/NYSE:TAK (https://www.takeda.com/investors/overview/)) today announced that the U.S. Food and Drug Administration (FDA) has approved ADZYNMA (ADAMTS13, recom
November 10, 2023 10:35
Aster Guardians Global Nursing Award 2024 Worth $250,000 to be Held in Bengaluru, India; Application Deadline Extended till 15th December
Aster Guardians Global Nursing Award 2024, an initiative by leading integrated healthcare provider Aster DM Healthcare, has extended the submission deadline to December 15th, 2023. Due to an overwhelm
November 09, 2023 10:15
Confluent Medical Sees Dramatic Improvements Around Supply Chain Visibility and Efficiency
Confluent Medical, a leading materials science, development and manufacturing partner to medical device manufacturers (“OEMs”), has experienced significant improvements to its end-to-end supply chain
Dr. Holger Zimmermann – Advisory Board Member Lysando AG
November 09, 2023 09:50
Pharma Leader Dr. Holger Zimmermann Joins Lysando's Advisory Board in Pioneering Fight Against Antibiotic-Resistant Bacteria
Lysando, a leading innovator in the fight against antibiotic-resistant bacteria, proudly announces the appointment of Dr. Holger Zimmermann to its Advisory Board. Dr. Zimmermann‘s distinguished career
November 08, 2023 16:55
Crown Bioscience Introduces OrganoidXplore: Revolutionizing Cancer Research with Rapid Large-scale Organoid Drug Screening
Crown Bioscience (https://www.crownbio.com/), a global contract research organization (CRO) and JSR Life Sciences company, today announced the launch of its ground-breaking service offering, OrganoidX
International Postdoctoral Scholars in Cancer Research, Class of 2023. Back Row: Dongqi Xie, Ph.D. (
November 08, 2023 16:50
Mary Kay Ash Foundation℠ Celebrates Five Years Shaping the Future of Cancer Research in Partnership With UT Southwestern Medical Center
The Mary Kay Ash Foundation (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fmarykayashfoundation.org%2F&esheet=53709537&newsitemid=20231107256704&lan=en-US&anchor=The+Mary+Kay+Ash+F
November 08, 2023 10:48
Takeda Announces Late-Breaking Data from Phase 2b Study of TAK-279, an Investigational, Oral, Once-Daily TYK2 Inhibitor, in Patients with Active Psoriatic Arthritis at American College of Rheumatology Convergence Annual Meeting
Takeda (TSE:4502/NYSE:TAK) today announced that the company will present positive results from its randomized, double-blind, placebo-controlled, Phase 2b trial evaluating TAK-279, an investigational o
HistoSonics Edison Histotripsy System (Photo: Business Wire)
November 07, 2023 14:05
HistoSonics Notches Significant Reimbursement Wins
HistoSonics, (www.histosonics.com), the manufacturer of the non-invasive Edison® Histotripsy System and novel sonic beam therapy, announced today that the Centers of Medicare & Medicaid Services (CMS)
November 05, 2023 10:20
Boehringer Ingelheim achieves major milestone in chronic kidney disease: aldosterone synthase inhibitor on top of empagliflozin delivers promising results in Phase II trial
Boehringer Ingelheim today announced promising 14-week Phase II data for BI 690517, a novel selective aldosterone synthase inhibitor (ASi). The results showed a significant reduction of albuminuria, a
November 05, 2023 09:50
Trailblazing the Future of Healthy Aging Science: Timeline® Hosts the First Global Urolithin A Summit With a Full-day Virtual Experience
On November 7th, the first global Urolithin A Scientific Summit, brought to the world stage by Timeline, is set to present paradigm-shifting research in the field of longevity. Led by experts in the s
T cells helping immune system to fight cancer cells in response to immunotherapies (Photo: Business
November 03, 2023 09:10
GE HealthCare Announces New Data Validating Artificial Intelligence Models for Predicting Patient Response to Immunotherapies
GE HealthCare’s Artificial Intelligence (AI) models predict patient response to immunotherapies with 70 to 80 percent accuracy[1], based on a pan-cancer cohort, according to findings to be presented a
November 02, 2023 09:40
Resolian Acquires China-Based Bioanalytical CRO Denali Medpharma
Resolian (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.resolian.com%2F&esheet=53720760&newsitemid=20231101490232&lan=en-US&anchor=Resolian&index=1&md5=1df79e5a4d8ec439af5c7de1
October 31, 2023 16:25
ReNAgade Therapeutics to Present Preclinical Data Demonstrating Potent Extra-Hepatic Delivery of mRNA Using Proprietary Lipid Nanoparticles at 11th International mRNA Health Conference
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced it will present preclinical data demonstrating novel and proprietary lipid nanoparticle (LNP)-base
Danny Bar-Zohar, Global Head of Research & Development and Chief Medical Officer for the Healthcare
October 30, 2023 17:37
Merck Strengthens Oncology Pipeline Through Strategic Partnership with Hengrui for Next-Generation Selective PARP1 Inhibitor and Antibody-Drug Conjugate
Merck, a leading science and technology company, today announced a strategic collaboration with Jiangsu Hengrui Pharmaceuticals Co. Ltd. (Hengrui). The partnership includes an exclusive license worldw
October 29, 2023 12:30
United States International Trade Commission Issues Exclusion Order for Infringing Apple Watches, Finding that Apple Violated U.S. Trade Laws
Masimo (https://www.masimo.com/)(NASDAQ: MASI) today announced that the United States International Trade Commission (USITC) has recommended a limited exclusion order for infringing Apple Watches with
October 27, 2023 17:27
Boehringer Ingelheim’s SPEVIGO® (spesolimab) wins 2023 Prix Galien USA Best Orphan/Rare Diseases Solution Award
Boehringer Ingelheim today announced that SPEVIGO® (spesolimab) has been recognized as Best Orphan/Rare Diseases Solution of 2023 by the Galien Foundation. The Prix Galien USA Award was presented last
October 27, 2023 16:50
GC Aesthetics and Bimini Health Tech Form Strategic Partnership to Advance Breast Reconstruction Solutions Globally
GC Aesthetics®, a long-established brand in breast aesthetics, and Bimini Health Tech (“Bimini”), a pioneer in healthcare solutions, are pleased to announce their groundbreaking Joint Venture partners
25 per page50 per page75 per page100 per page